Romaco delivers first Siebler StripTabs to Indian contract manufacturer

Published: 22-Jan-2010
Packaging Drug Delivery Pharmaceutical

Romaco has developed its first Siebler StripTabs line for Ankur Drugs and Pharma, based in Baddi and Daman, India.

Romaco has developed its first Siebler StripTabs line for Ankur Drugs and Pharma based in Baddi and Daman, India. It will be used for the production and packaging of pharmaceutical orally dissolving strips for pain and hormone therapies, as well as for treating erectile disfunction. Taken orally, the wafer-thin StripTabs dissolve on the tongue in seconds.

This type of medication, based on a starch and polymer solution, is currently being considered as a carrier for more than 600 different APIs.

"This innovative pharmaceutical dosage form has the potential dramatically to change and expand the landscape of traditional dosage forms," says Purnandu Jain, chief executive of Ankur Drugs and Pharma.

The Indian company is currently using more than 50 blister and strip packaging lines, cartoners, tube fillers, as well as aseptic powder filling lines made by packaging specialist Romaco of Karlsruhe, Germany. It currently produces and packages more than 400 different drugs for the Indian, Asian and African pharmaceutical markets.

Customised manufacturing and packaging processes are needed to handle the thumb-sized strip dosage forms, which are only 60-100μm thick. First, the active pharmaceutical ingredient suspension is prepared using a homogenising process on a vacuum-processing unit made by Romaco FrymaKoruma. Directly blending in the APIs, right at the beginning of the process, results in high dosing accuracy, the company says.

The liquid is then applied with a thickness tolerance of 1μm to a high-precision substrate film. After being conveyed through several drying units, the coated strips are wound into rolls with widths of up to 240mm, which are transferred to a Siebler HM 2/500 heat sealing machine for further processing.

After unrolling, the coated substrate strips are conveyed through the unit's cutting station and the film tablets cut to the required dimensions of 20 x 30mm, leaving the carrier material intact.

In the next step, the cut strips are pulled over a sharp-edged dispensing tongue where they become separated from the substrate film and are conveyed as individual units to the sealing area.

A shuttle system carries the individual film tablets onto the primary packaging film with a sealing width of up to 500mm.

The StripTabs then come to the HM 2/500's ten-line sealing process, which has a maximum packaging speed of 1,500 strips/min. Sealed in light- and moisture-proof soft aluminum foil pouches, the StripTabs have a shelf life of up to three years.
See more

You may also like

Manufacturing

Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform

Read more
The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering

Trending Articles

  1. Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development
  2. FDA approves Lilly's oral GLP-1 pill Foundayo for obesity with no food or water restrictions Eli Lilly has received FDA approval for Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist for adults with obesity or overweight that requires no fasting or water restrictions, with clinical trial participants on the highest dose losing an average of 27 pounds
  3. L.B. Bohle hosts successful continuous manufacturing workshop in Brazil Focus on continuous wet granulation and drying for research, development and small-scale production
  4. From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND Join ACG in partnership with Manufacturing Chemist for an expert-led session to explore how different wet granulation methods impact consistency, yield, and quality — and what really matters when it comes to selecting and optimising your process
  5. FDA warns of drug-induced liver injury risk with Amgen's Tavneos after deaths The US Food and Drug Administration has issued a safety warning linking Amgen's vasculitis drug Tavneos to 76 cases of drug-induced liver injury globally, including eight deaths and seven cases of vanishing bile duct syndrome, recommending comprehensive liver monitoring during the first five months of treatment

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform

The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering
Manufacturing

L.B. Bohle hosts successful continuous manufacturing workshop in Brazil

Focus on continuous wet granulation and drying for research, development and small-scale production
Manufacturing

Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development

Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development
Regulatory

FDA approves Lilly's oral GLP-1 pill Foundayo for obesity with no food or water restrictions

Eli Lilly has received FDA approval for Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist for adults with obesity or overweight that requires no fasting or water restrictions, with clinical trial participants on the highest dose losing an average of 27 pounds
Packaging

PulPac unveils plastic-like fiber caps

The caps will be presented publicly for the first time at interpack 2026, demonstrating how fiber can move into one of the most widely used and technically demanding components in packaging
Pharmaceutical

Tekpak Automation to showcase pharma pick-and-place robotic cell at interpack 2026

Tekpak Automation will demonstrate the benefits of robotics for pharmaceutical applications at interpack 2026, with a LIVE working demonstration of a 3-axis pick-and-place cell handling medipens on Stand A15/Hall 16
Regulatory

FDA warns of drug-induced liver injury risk with Amgen's Tavneos after deaths

The US Food and Drug Administration has issued a safety warning linking Amgen's vasculitis drug Tavneos to 76 cases of drug-induced liver injury globally, including eight deaths and seven cases of vanishing bile duct syndrome, recommending comprehensive liver monitoring during the first five months of treatment
Subscribe now